Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial. [electronic resource]
Producer: 20190910Description: 614-623 p. digitalISSN:- 1537-6613
- Adult
- Antibodies, Viral -- blood
- Antibody-Dependent Cell Cytotoxicity
- Cross Reactions
- Double-Blind Method
- Drug Carriers
- Female
- Hemagglutination Inhibition Tests
- Hemagglutinin Glycoproteins, Influenza Virus -- genetics
- Humans
- Immunization Schedule
- Influenza A Virus, H5N1 Subtype -- genetics
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- prevention & control
- Male
- Neutralization Tests
- Protein Array Analysis
- T-Lymphocytes -- immunology
- Vaccines, Synthetic -- administration & dosage
- Vaccinia virus -- genetics
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.